Nucleix’s Bladder EpiCheck, urine test for monitoring bladder cancer, chosen as standard-of-care by Radboud University Medical Center
Prof. Fred Witjes, Radboud University Medical Center: “Because of the exceptional, clinically-proven, high performance of Bladder EpiCheck, we can now substitute an invasive procedure for detecting recurrent bladder cancer with a simple urine test”. Prof. Fred Witjes: “The system also allows us, for the first time, to collect urine samples directly from the patient’s home”.
Subscription Confirmation Required
Go to your email inbox
Go to the inbox of the email
address you just used to sign up.
Open the confirmation email
Find the email sent by us. It has the subject line
“Nucleix: Please Confirm Subscription” and I
sent from “info@nucleix.com”.
Click the confirmation link
Click on the link inside the <br>email and you’re good to go.